• HOME
  • Topics
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Inter-professional and inter-departmental alcoholism rehabilitation program
Masahiro Kikuchi, Naomi Matsutani, Ryota Ishihara, Masako Sugihara, Yuuki Mizuno, Chiyo Chiba, Takahiro Ohta, Eri Yamada, Sota Oguro, Yasuko Sato, Hiroki Bessho, Yoshinori Horie
Clin Mol Hepatol. 2020;26(4):626-632.   Published online October 1, 2020
View: 2697   Download: 60
Programmed cell death in alcohol-associated liver disease
Tatsunori Miyata, Laura E. Nagy
Clin Mol Hepatol. 2020;26(4):618-625.   Published online September 21, 2020
View: 8124   Download: 221  Citations: 23
Autophagy and liver cancer
Xiaojuan Chao, Hui Qian, Shaogui Wang, Sam Fulte, Wen-Xing Ding
Clin Mol Hepatol. 2020;26(4):606-617.   Published online October 1, 2020
View: 5957   Download: 197  Citations: 30
From intestinal dysbiosis to alcohol-associated liver disease
Beatriz Garcia Mendes, Bernd Schnabl
Clin Mol Hepatol. 2020;26(4):595-605.   Published online September 11, 2020
View: 5846   Download: 196  Citations: 16
Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake
Seonghwan Hwang, Tianyi Ren, Bin Gao
Clin Mol Hepatol. 2020;26(4):586-594.   Published online September 17, 2020
View: 4677   Download: 172  Citations: 10
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Dong Joon Kim, Won-Il Jeong, Hidekazu Tsukamoto, Bin Gao
Clin Mol Hepatol. 2020;26(4):584-585.   Published online October 1, 2020
View: 2452   Download: 68
Letter to the Editor
Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
Dimitrios Patoulias, Michael Doumas
Clin Mol Hepatol. 2020;26(4):582-583.   Published online September 25, 2020
View: 2407   Download: 63  Citations: 2
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
Jeong Su Park, Soo Han Bae
Clin Mol Hepatol. 2020;26(4):577-578.   Published online September 17, 2020
View: 2495   Download: 59  Citation: 1
Original Article
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park
Clin Mol Hepatol. 2020;26(4):562-576.   Published online October 1, 2020
View: 4738   Download: 170  Citations: 21
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
Desmond Y. H. Yap, Kevin S. H. Liu, Yu-Chun Hsu, Grace L. H. Wong, Ming-Chang Tsai, Chien-Hung Chen, Ching-Sheng Hsu, Yee Tak Hui, Michael K. K. Li, Chen-Hua Liu, Yee-Man Kan, Ming-Lung Yu, Man-Fung Yuen
Clin Mol Hepatol. 2020;26(4):554-561.   Published online August 28, 2020
View: 3476   Download: 161  Citations: 7
Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong
Clin Mol Hepatol. 2020;26(4):540-553.   Published online September 17, 2020
View: 4592   Download: 148  Citations: 17
Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway
Seulki Lee, Eun Ji Choi, Eun Ju Cho, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol. 2020;26(4):529-539.   Published online August 24, 2020
View: 5357   Download: 197  Citations: 23
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol. 2020;26(4):516-528.   Published online September 11, 2020
View: 4230   Download: 174  Citations: 29
Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial
Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee
Clin Mol Hepatol. 2020;26(4):506-515.   Published online July 10, 2020
View: 4320   Download: 170  Citations: 29
The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma
Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong
Clin Mol Hepatol. 2020;26(4):492-505.   Published online July 10, 2020
View: 11304   Download: 285  Citations: 27
More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
Paul Kwo, Deepti Dronamraju
Clin Mol Hepatol. 2020;26(4):489-491.   Published online September 24, 2020
View: 2757   Download: 67  Citation: 1
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
Jaewhan Song
Clin Mol Hepatol. 2020;26(4):484-486.   Published online October 1, 2020
View: 4422   Download: 112  Citations: 7
Long-term prognosis and management of hepatocellular carcinoma after curative treatment
Naoshi Nishida
Clin Mol Hepatol. 2020;26(4):480-483.   Published online September 21, 2020
View: 3825   Download: 95  Citations: 8
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2020;26(4):461-475.   Published online September 10, 2020
View: 6077   Download: 243  Citations: 25
Managing liver cirrhotic complications: Overview of esophageal and gastric varices
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
Clin Mol Hepatol. 2020;26(4):444-460.   Published online October 1, 2020
View: 8069   Download: 523  Citations: 37
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung-Soo Kim, Byung-Wan Lee
Clin Mol Hepatol. 2020;26(4):430-443.   Published online August 14, 2020
View: 6837   Download: 389  Citations: 25
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
Clin Mol Hepatol. 2020;26(4):411-429.   Published online August 28, 2020
View: 11245   Download: 1,183  Citations: 44
Liver graft from donation after circulatory death donor: Real practice to improve graft viability
Koji Hashimoto
Clin Mol Hepatol. 2020;26(4):401-410.   Published online July 10, 2020
View: 3843   Download: 137  Citations: 4
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray
Clin Mol Hepatol. 2020;26(4):383-400.   Published online July 17, 2020
View: 7330   Download: 463  Citations: 37
Letter to the Editor
Macro-aspartate aminotransferase in a healthy woman
Maria Lorubbio, Agostino Ognibene, Benedetta Salvadori, Alessandra Fanelli, Giacomo Laffi
Clin Mol Hepatol. 2020;26(3):378-381.   Published online June 23, 2020
View: 3370   Download: 113  Citations: 2
How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
Hye Won Lee, Beom Kyung Kim
Clin Mol Hepatol. 2020;26(3):376-377.   Published online June 11, 2020
View: 3141   Download: 104  Citation: 1
Original Article
Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
Seung Bum Lee, Joonho Jeong, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung-Jo Bang, Jung Woo Shin, Bo Ryung Park, Eun Ji Park, Neung Hwa Park
Clin Mol Hepatol. 2020;26(3):364-375.   Published online May 29, 2020
View: 4311   Download: 240  Citations: 12
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
Clin Mol Hepatol. 2020;26(3):352-363.   Published online May 28, 2020
View: 3484   Download: 165  Citations: 2

Clinical and

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail:
Copyright © The Korean Association for the Study of the Liver.         
TODAY : 1454
TOTAL : 1212619
Close layer